Ditchcarbon
  • Customers
  1. Organizations
  2. Merus N.V.
Public Profile
Pharmaceutical Preparation Manufacturing
NL
updated 5 months ago

Merus N.V.

Company website

Merus N.V., a pioneering biotechnology company headquartered in the Netherlands, focuses on the development of innovative bispecific antibody therapeutics. Founded in 2003, Merus has established itself as a leader in the biopharmaceutical industry, particularly in the fields of oncology and immunology. The company’s unique proprietary technology platform, known as the Biclonics® platform, enables the creation of bispecific antibodies that can simultaneously target multiple antigens, offering potential advantages in treating complex diseases. With a strong presence in Europe and North America, Merus has achieved significant milestones, including successful clinical trials and strategic partnerships with major pharmaceutical companies. The company’s commitment to advancing cancer treatment through its core products positions it as a notable player in the competitive biotech landscape, dedicated to improving patient outcomes and transforming therapeutic approaches.

DitchCarbon Score

How does Merus N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Merus N.V.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Merus N.V.'s reported carbon emissions

Merus N.V., headquartered in the Netherlands, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As of now, Merus N.V. does not inherit emissions data from a parent company, nor does it participate in any significant climate pledges or initiatives that would provide a framework for future emissions reductions. The absence of reported emissions and climate commitments indicates a potential area for development in their sustainability strategy. In the context of the industry, it is essential for companies like Merus N.V. to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Merus N.V.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Merus N.V. is in NL, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Merus N.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Harbour Antibodies BV

NL
Updated 11 days ago

AbCellera

CA
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Genmab

DK
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Zymeworks Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

RenBio, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy